Navigation Links
GeoVax Labs, Inc. Provides Clinical Studies Update
Date:8/5/2009

infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with HIV).

GeoVax's core AIDS vaccine technologies were developed by Dr. Harriet Robinson, Senior V.P. of Research and Development, through a collaboration of colleagues at Emory University's Vaccine Center, the National Institutes of Health (NIH), The Centers for Disease Control and Prevention (CDC) and GeoVax.

GeoVax's AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) based in Seattle, Washington. The HVTN, funded through a cooperative agreement with the National Institutes of Health (NIH), is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $17 million IPCAVD grant awarded in late 2007.

Safe Harbor Statement

All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effec
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. GeoVax Labs, Inc. Announces Resignation of Director
2. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
3. GeoVax to Exhibit at the 2009 BIO International Convention
4. GeoVax Labs, Inc. Announces First Quarter Financial Results
5. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
6. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
7. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
8. GeoVax to Present at the BIO CEO & Investor Conference 2009
9. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
10. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
11. GeoVax Presents Data at AIDS Vaccine 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... NATICK, Mass., Dec. 14 Boston Scientific Corporation ... of a public offering of $2 billion aggregate principal ... registration statement. The public offering consists of $850 ... million of 6.00 percent notes due January 2020 and ... Boston Scientific plans to use the net proceeds ...
(Date:12/14/2009)... Dec. 14 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, owing to ... fibrillation drug market will increase more than sevenfold ... in 2018 in the United States, France, Germany, ... The new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), today announced ... from sales of Thalomid® during the third quarter ... In addition, the Company anticipates a decrease ... 2009. The difference in estimated and actual ... in the fourth quarter financial results. ,, (Logo: ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2
... ZMH ; SWX: ZMH) announced that certain of ... from Abbott for approximately,$360 million in cash. Zimmer said ... hand and borrowings under existing credit facilities., The ... of 2008. The,boards of directors of both companies have ...
... Colo., Sept. 4 InVitria,( http://www.invitria.com ... animal free,products that enhance productivity, safety ... the biopharmaceutical, cell culture, life science ... of Cambridge Healthtech,Institute,s 4th Annual "Optimizing ...
... and National Development in Taiwan, 1950-2000, Celebrates ... Editor of a Comprehensive History of ... Dialogue on a National Health Care System ... Worth Studying, NEW YORK, Sept. 4 ...
Other Biology Technology:Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 2Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 3Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 4InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference 2ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 2ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 3
(Date:12/11/2009)... in French . , Montreal, December ... molecular mechanism that prevents cancer. In the December 11 ... scientists from the Universit de Montral and the Universit ... molecule prevents the cancer-causing activity of cytokines, hormones that ... Crohns, in smokers and people exposed to asbestos. ...
(Date:12/11/2009)... growers, profits have traditionally been limited by ... growing seasons can be short. Thanks to ... are being introduced that offer growers the ... in economic bonuses for both producers and ... of blackberry called "primocane-fruiting", which bear fruit ...
(Date:12/11/2009)... best dietary source of Omega 3, according to a study ... The scientists analysed the eggs, or roe, of 15 marine ... these fatty acids, which are essential to the human body. ... the nutritional potential of the roe of marine animals, but ... that this is one of the best natural sources of ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 1CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 2CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 3CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 4R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 1R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 2R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 3New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 1New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 2New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 3New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 4New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 5New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 6
... Acid rain was one of the worlds worst pollution problems ... Britain, as well as Europe and North America. , In ... been acidified, harming fish, stream insects and river birds such ... has been taken across Europe to clean up acid pollutants ...
... States participating in the GMES Programme approved the transition ... Component Programme. , Oversubscription of the programme by the ... with oversubscription to phase 2 of 116%, giving a ... the programme will allow ESA to confirm the development ...
... the United States is a neurological event such as ... cause, the brain is often quickly and irreversibly damaged. ... the National Institutes of Health, will study point-of-care technologies ... neurologic emergencies. The result is the "Point-of-Care Center for ...
Other Biology News:Recovery from acid rain 'much slower than expected' 2NIH awards UC $9 million grant to improve patient point-of-care technologies 2NIH awards UC $9 million grant to improve patient point-of-care technologies 3
The Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 6 microcentrifuge tubes....
... the 9, 10, 12, and 13 positions. It ... for the quantification of 9(S)-HODE by GC- or ... of linoleic acid in both plants and animals. ... an esterified component of membrane phospholipids and in ...
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
...
Biology Products: